Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
David M. Kurtz(Stanford University), Joanne Soo(Stanford University), Lyron Co Ting Keh(Stanford University), Stefan Alig(Stanford University), Jacob J. Chabon(California Institute for Regenerative Medicine), Brian J. Sworder(Stanford University), André Schultz(Stanford University), Michael C. Jin(Stanford University), Florian Scherer(University of Freiburg), Andrea Garofalo(Stanford University), Charles Macaulay(Stanford University), Emily G. Hamilton(Stanford University), Binbin Chen(Stanford University), Mari Olsen(Stanford University), Joseph G. Schroers‐Martin(Stanford University), Alexander Craig(Stanford University), Everett J. Moding(Stanford University), Mohammad Shahrokh Esfahani(Stanford University), Chih Long Liu(Stanford University), Ulrich Dührsen(Essen University Hospital), Andreas Hüttmann(Essen University Hospital), Olivier Casasnovas(Inserm), Jason R. Westin(The University of Texas MD Anderson Cancer Center), Mark Roschewski(National Institutes of Health), Wyndham H. Wilson(National Institutes of Health), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Davide Rossi(Institute of Oncology Research), Maximilian Diehn(California Institute for Regenerative Medicine), Ash A. Alizadeh(Institute for Stem Cell Biology and Regenerative Medicine)
Cited by 361Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis